Martin Makary, 27th Commissioner of the U.S. FDA, shared a post on X:
“Let’s bring the different pharma companies to the table and see if they can address this problem. I’ve met with them and they’re well aware that the price of some of these drugs are 5, 10, 12 times higher in the United States than they are in London, and Germany, and France. That doesn’t make sense. It doesn’t make sense to any voter out there.”
Proceed to the video attached to the post.
More posts featuring Martin Makary on OncoDaily.